搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
金融界财经 on MSN
1 天
RBC发布2025年30大金股:瞄准能源与科技新机遇
RBC Capital Markets周一发布了其2025年的首选股名单,其中包括一家能源巨头和一家重要的金融公司。
13 小时
on MSN
Bank of Montreal, Canadian Imperial Bank upgraded to Outperform at RBC
RBC Capital Markets upgraded Bank of Montreal (NYSE:BMO) and Canadian Imperial Bank of Commerce (NYSE:CM) to Outperform from ...
EconoTimes
22 小时
RBC Upgrades Utilities Sector While Downgrading Energy
RBC Capital Markets has upgraded the Utilities sector to Overweight, naming it the top defensive sector, while downgrading ...
2 天
RBC Capital维持Constellation Brands股票目标价
RBC Capital Markets预计,在对政府政策计划和公司可能采取的应对措施有更清晰的了解之前,STZ股价将保持区间波动。尽管当前市场面临挑战,但该公司的渠道调查显示,本季度的消耗率约为3.5%,略低于共识预期。
18 小时
Canadian dollar seen higher but upside limited by US tariff threat: Reuters poll
The Canadian dollar is set to recoup only a small part of its recent losses in the coming year as expected U.S. trade tariffs ...
3 天
Top 30 global stock ideas from RBC Capital Markets analysts
The research team at RBC Capital Markets published their top 30 global stock ideas for 2025, ...
2 天
on MSN
Potential rise in M&A not yet priced into options market, says RBC Capital Markets' Amy Wu ...
Amy Wu Silverman, RBC Capital Markets head of derivatives strategy, joins CNBC's 'Squawk Box' to discuss market outlooks, ...
1 天
RBC quantitative analyst makes 10 changes to his top 40 Canadian stock picks
Scotiabank analyst Mario Saric thinks the worst may be over for domestic office REITs, ...
1 天
RBC Capital重申Ultragenyx的"跑赢大市"评级,看好成骨不全症药物前景
该公司对Ultragenyx的成骨不全症 (OI)药物持乐观态度,预计第三期临床试验数据即将发布。尽管RBC Capital承认试验存在风险,如第二期试验样本量小、第三期患者病情更重以及安慰剂反应建模困难等,但仍对该药物的潜在成功持乐观态度。
1 天
US stock market: RBC upgrades Utilities, downgrades Energy
On the other hand, RBC downgraded the Energy sector to Market Weight from Overweight. According to the note, the move was ...
1 天
BMO stock gets 20% price target hike, upgrade to 'Outperform' from RBC
Mihelic hiked his price target on Toronto-listed BMO shares from $133 to $161, while upgrading his rating to “Outperform” ...
2 天
Johnson & Johnson (JNJ) Gets a Buy from RBC Capital
RBC Capital analyst Shagun Singh Chadha maintained a Buy rating on Johnson & Johnson (JNJ – Research Report) on January 6 and set a price ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈